The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N,N2,N2-Trimethyl-N-{[4'-(morpholin-4-yl)biphenyl-3-yl]methyl}glycinamide (2R,3R)-tartrate ID: ALA3985575
PubChem CID: 134157682
Max Phase: Preclinical
Molecular Formula: C26H35N3O8
Molecular Weight: 367.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)CC(=O)N(C)Cc1cccc(-c2ccc(N3CCOCC3)cc2)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O
Standard InChI: InChI=1S/C22H29N3O2.C4H6O6/c1-23(2)17-22(26)24(3)16-18-5-4-6-20(15-18)19-7-9-21(10-8-19)25-11-13-27-14-12-25;5-1(3(7)8)2(6)4(9)10/h4-10,15H,11-14,16-17H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
Standard InChI Key: ISHQPYYRBDVSQB-LREBCSMRSA-N
Molfile:
RDKit 2D
37 38 0 0 0 0 0 0 0 0999 V2000
15.8492 -5.1252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5581 -3.8974 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2669 -5.9437 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5581 -4.7159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2669 -5.1252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9758 -4.7159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8492 -5.9437 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1403 -4.7159 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9758 -3.8974 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6847 -5.1252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.0456 -1.7744 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7545 -2.1836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0456 -0.9558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3368 -2.1836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2101 -1.7744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9190 -2.1836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6279 -1.7744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6279 -0.9558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9190 -0.5465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2101 -0.9558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5012 -2.1836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7923 -1.7744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0835 -2.1836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0835 -3.0022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7923 -3.4115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5012 -3.0022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7545 -3.0008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4622 -1.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1699 -2.1836 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3786 -3.4095 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6711 -2.9988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9655 -3.4039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9613 -4.2214 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6688 -4.6322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3806 -4.2254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8776 -1.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1699 -3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 4 1 0
4 2 1 6
4 5 1 0
5 3 1 6
5 6 1 0
1 7 2 0
1 8 1 0
6 9 2 0
6 10 1 0
11 12 1 0
11 13 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
21 26 2 0
15 21 1 0
14 17 1 0
11 14 1 0
12 27 2 0
12 28 1 0
28 29 1 0
30 31 1 0
30 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
24 30 1 0
29 36 1 0
29 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.49Molecular Weight (Monoisotopic): 367.2260AlogP: 2.71#Rotatable Bonds: 6Polar Surface Area: 36.02Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.50CX LogP: 2.57CX LogD: 2.22Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.79Np Likeness Score: -1.62
References 1. Yamaki S, Suzuki D, Fujiyasu J, Neya M, Nagashima A, Kondo M, Akabane T, Kadono K, Moritomo A, Yoshihara K.. (2017) Synthesis and structure activity relationships of glycine amide derivatives as novel Vascular Adhesion Protein-1 inhibitors., 25 (1): [PMID:27810440 ] [10.1016/j.bmc.2016.10.025 ]